TGFB1 and kidney failure: Recent work from our group has demonstrated that combination therapy of paricalcitol and enalapril improved renal function and histology, suppressing the progression of renal failure via mediation/inhibition of the TGFβ-1 signaling pathway [7, 18, 19].